comparemela.com

Latest Breaking News On - Health joint committee - Page 1 : comparemela.com

Covid-19 news: US authorities call for Johnson & Johnson vaccine pause

Gabrielle Lurie/The San Francisco Chronicle via Getty Images Latest coronavirus news as of 5pm on 13 April There have been six reports of rare blood clots among more than 6.8 million people in the US who received the Johnson & Johnson vaccine US health authorities, including the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), recommended a pause in the use of the Johnson & Johnson covid-19 vaccine on 13 April as a precautionary measure, following reports of rare blood clots in six people who had received the vaccine. More than 6.8 million doses of the single-shot vaccine had been administered across the US as of 13 April. Among these, there were six reports of a rare blood clotting condition called cerebral venous sinus thrombosis (CVST), which affects blood vessels in the brain, all of which were among women aged 18 to 48. A special meeting of the CDC’s Advisory Committee on Immunization Practices will review the reports on 14 April,

Covid-19 news: EU drugs regulator reviewing Johnson & Johnson vaccine

Stephen Zenner/SOPA Images/Shutterstock Latest coronavirus news as of 5pm on 9 April The EU’s medicines regulator is reviewing a small number of reports of rare blood clots in people who received the Johnson & Johnson vaccine The European Union’s medicines regulator is reviewing four reported cases of rare blood clots associated with low levels of platelets – small particles in the blood that normally help in clotting – including one case which was fatal, in people who received the Johnson & Johnson covid-19 vaccine. The European Medicines Agency (EMA) is also reviewing five reported cases of a bleeding condition, called capillary leak syndrome, in people who received the Oxford/AstraZeneca covid-19 vaccine. “At this stage, it is not yet clear whether there is a causal association” between the vaccines and the reported conditions, the EMA said. Both the Oxford/AstraZeneca and Johnson & Johnson vaccines are based on viral vector technologies, which use inactivated cold

Covid-19 news: Italy, Spain, Belgium limit use of AstraZeneca vaccine

Covid-19 news: Italy, Spain, Belgium limit use of AstraZeneca vaccine
newscientist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newscientist.com Daily Mail and Mail on Sunday newspapers.

Covid-19 news: UK to offer under-30s alternative to AstraZeneca jab

Marco Cantile/LightRocket via Getty Images Latest coronavirus news as of 5pm on 7 April UK committee advises under-30s be offered alternative to AstraZeneca jab, while EU review finds no evidence age or gender are risk factors for side effects The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that people under the age of 30 with no underlying health conditions should be offered an alternative covid-19 vaccine instead of the Oxford/AstraZeneca shot where possible, due to evidence linking the vaccine to rare blood clots. A review by the UK’s medicines regulator found that by the end of March, 79 people in the UK had experienced rare blood clots following vaccination with the Oxford/AstraZeneca vaccine – 19 of whom had died. The UK Medicines and Healthcare products Regulatory Agency (MHRA) said this was not definitive evidence that the vaccine caused the clots but said the link was becoming firmer. However, both the MHRA in the UK and the EU’s medici

Covid-19 news: There may be a million people with long covid in UK

Covid-19 news: There may be a million people with long covid in UK
newscientist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newscientist.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.